Optimizing Treatment Strategies in Relapsed/Refractory Metastatic CRC

home / insights / optimizing-treatment-strategies-crc
Continuum of Care for Metastatic CRC

EP. 1: Continuum of Care for Metastatic CRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Initiating Therapy for mCRC

EP. 2: Initiating Therapy for mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Second-Line Treatment for mCRC

EP. 3: Second-Line Treatment for mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Later Lines of Therapy for mCRC

EP. 4: Later Lines of Therapy for mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
CORRECT, RECOURSE, and ReDOS Trials in mCRC

EP. 5: CORRECT, RECOURSE, and ReDOS Trials in mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Therapeutic Agents in Relapsed/Refractory mCRC

EP. 6: Therapeutic Agents in Relapsed/Refractory mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Sequencing in mCRC: Later-Line Therapies

EP. 7: Sequencing in mCRC: Later-Line Therapies

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Using I/O in MSI-H Tumors in mCRC

EP. 8: Using I/O in MSI-H Tumors in mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Role of I/O Combination Therapies in mCRC

EP. 9: Role of I/O Combination Therapies in mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Key Trials in mCRC: I/O Combination Therapies

EP. 10: Key Trials in mCRC: I/O Combination Therapies

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020
Future Directions in Later Line Therapy for mCRC

EP. 11: Future Directions in Later Line Therapy for mCRC

Fortunato Ciardiello, MD, PhD, University of Campania;Axel Grothey, MD, West Cancer Center & Research Institute;Heinz-Josef Lenz, MD, FACP, USC Norris Comprehensive Cancer Center
June 29th 2020